HOME >> MEDICINE >> NEWS
Mayo Clinic investigates new device to regulate beating of the heart and improve pump function

ROCHESTER, MINN. -- Mayo Clinic cardiologists are investigating the use of a new pacemaker-defibrillator device that may offer new hope for patients with heart failure who also have potentially dangerous uncoordinated or irregular contractions of the heart.

Up to 50 percent of people with advanced heart failure develop abnormalities of the heart's electrical impulses, which disturb the timing of the contractions of the heart's two lower chambers, called ventricles, so that they do not contract simultaneously. When this occurs, the symptoms of heart failure, including shortness of breath, fatigue and swelling of the feet and ankles, may worsen, thereby decreasing the pumping efficiency of the heart.

"This device delivers small electrical impulses to the left and right chambers of the heart, to better synchronize the contractions of the heart's lower chambers," says Mayo Clinic cardiologist and study investigator, Paul Friedman, M.D. "We will investigate if this therapeutic approach improves the quality of life for patients with heart failure."

Until now, traditional heart failure therapies have included: medications, lifestyle modifications and heart transplant.

Heart failure affects about five million people in the United States. This debilitating disease is the most frequent cause of hospitalization for people age 65 and older, and often leads to premature death. Healthcare costs associated with caring for those with heart failure in the United States is nearly $10 billion annually.

The main purpose of the study is to assess the safety and effectiveness of the device in patients with heart failure who are also indicated for a traditional defibrillator and meet the other entry criteria.

The study will involve up to 35 investigational centers in the U.S. and will enroll 300 participants nationwide.

The device, which is the size of a small pager (66 cc), is implanted under the skin in the chest area, and three thin wires (calle
'"/>

Contact: John Murphy
murphy.johnj@mayo.edu
507-538-1385
Mayo Clinic
27-Oct-1999


Page: 1 2

Related medicine news :

1. Mayo Clinic discovers new pathway against pancreatic cancer
2. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
3. Mayo Clinic study sets threshold for valve repair surgery
4. Mayo Clinic researcher calls for improved newborn screening
5. Mayo Clinic study finds obese kidney donors face few increased risks
6. Mayo Clinic identifies key cellular process in prostate and other cancers
7. Clinical breast examination offers modest benefit to breast cancer screening program
8. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
9. Clinicians report missing patient information is common
10. Mayo Clinic discovers a key to low metabolism and major factor in obesity
11. Clinical trial of Etanercept for Wegeners disease shows no benefit

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 10, 2020 , ... 3Lions Publishing, Inc. (3LP), ... Partner Vetting (BPV) Portal . Expresso® 3.0 contains a Portal where potential and ... mailing, tracking, and performing other administrative tasks that amount to thousands of ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... featured in Biocompare’s latest content hub— Future Lab: COVID-19 R&D . , ... advancements, trends, news, and products within specific scientific niches. Since their launch four ...
(Date:7/2/2020)... (PRWEB) , ... July 02, 2020 , ... ... its annual Outstanding Safety Professional of the Year Award to Eric Simmons of ... from more than 250 nominations. Simmons, who holds a master’s degree in occupational ...
(Date:7/1/2020)... ... July 01, 2020 , ... Psilera Bioscience ... psychedelics and analogues, announces its core executive team. The co-founders Drs. Jackie Salm ... novel formulations, and as distinguished researchers within the cannabis industry. They are joined ...
(Date:6/28/2020)... ... ... PathAI, a global provider of artificial intelligence (AI)-powered technology for use in ... PD-L1 expression to assess response in patients treated with Bristol Myers Squibb’s PD-1 inhibitor, ... Research (AACR) Annual Meeting. AACR was held June 22 to June 24. , The ...
Breaking Medicine News(10 mins):
(Date:6/25/2020)... , ... June 25, 2020 , ... ... by Innovate UK to build a distributed ledger platform to store COVID-19 related ... August, Billon will provide a fully functioning prototype for publishing, sharing and verifying ...
(Date:6/25/2020)... ... June 25, 2020 , ... The FSHD Society ... , which is being conducted entirely online for the first time in the ... the discussion and dissemination of state-of-the-art research on facioscapulohumeral muscular dystrophy (FSHD). A ...
(Date:6/24/2020)... ... June 24, 2020 , ... The Safe Boating Campaign, a worldwide effort ... under the influence, or BUI, is the leading contributing factor in recreational boater deaths, ... corner, and unfortunately has become known for drinking and boating, and deadly accidents,” said ...
Breaking Medicine Technology:
Cached News: